To see the other types of publications on this topic, follow the link: Vaccinia virus.

Dissertations / Theses on the topic 'Vaccinia virus'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Vaccinia virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Chan, Kenneth See Kit. "Nef from pathogenic simian immunodeficiency virus attenuates vaccinia virus /." For electronic version search Digital dissertations database. Restricted to UC campuses. Access is free to UC campus dissertations, 2004. http://uclibs.org/PID/11984.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wallengren, Kristina. "Envelopment of retrovirus and vaccinia virus /." Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4851-8/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kettle, Susan. "Characterisation of vaccinia virus gene B13R." Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294390.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Moore, Jeffrey B. "Vaccinia virus 3[beta]-hydroxysteroid dehydrogenase." Thesis, University of Oxford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.359450.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Keller, Brian Andrew. "Functional Genomic Studies of Vaccinia Virus Provide Fundamental Insights into Virus-Host Interactions." Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36614.

Full text
Abstract:
The oncolytic virus field is in the midst of strong and sustained growth. The clinical utility of this class of therapeutics has been bolstered in recent years by the rise of immune checkpoint inhibition, which has the potential to work synergistically with oncolytic viruses to increase the scope of patients who respond favourably to therapy. This growth has been further driven by clear industry support with several pharmaceutical companies acquiring or developing oncolytic virus products following the 2015 FDA approval of Talimogene laherparepvec and the generally-accepted potential of immuno
APA, Harvard, Vancouver, ISO, and other styles
6

Bleckwenn, Nicole Aleece. "Protein production development with recombinant vaccinia virus." College Park, Md. : University of Maryland, 2004. http://hdl.handle.net/1903/1416.

Full text
Abstract:
Thesis (Ph. D.) -- University of Maryland, College Park, 2004.<br>Thesis research directed by: Chemical Engineering. Title from t.p. of PDF. Includes bibliographical references. Published by UMI Dissertation Services, Ann Arbor, Mich. Also available in paper.
APA, Harvard, Vancouver, ISO, and other styles
7

Gardner, Jeremy Damien. "Characterisation of the vaccinia virus gene A39R." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.365448.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Major, James R. "Interactions of dendritic cells with vaccinia virus." Thesis, University of Oxford, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401096.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Odell, Mark. "An analysis of vaccinia virus DNA ligase." Thesis, University of Oxford, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Napoli, Andrea. "Glycerophospholipid fluorescence imaging during vaccinia virus replication." Thesis, Sorbonne Paris Cité, 2019. https://theses.md.univ-paris-diderot.fr/NAPOLI_Andrea_1_va_20190415.pdf.

Full text
Abstract:
Le virus de la vaccine (VACV) est l'organisme modèle pour l'étude des Poxviridae. Son cycle de réplication dans le cytoplasme de la cellule hôte a été largement étudié par microscopie optique et microscopie électronique. Grâce à des études génétiques approfondies, le rôle de certaines des 250 protéines du virus a été élucidé. Cependant, les mécanismes d’acquisition de la membrane du virus, notamment le rôle des lipides cellulaires impliqués, restent mal connus. L’étude de la composition des membranes de VACV purifiés par spectrométrie de masse a montré qu’elles présentent un enrichissement en
APA, Harvard, Vancouver, ISO, and other styles
11

Jarmin, Susan Anne. "Vaccinia virus protein A40 is an immunomodulator." Thesis, Imperial College London, 2009. http://hdl.handle.net/10044/1/4717.

Full text
Abstract:
Vaccinia virus (VACV) strain Western Reserve gene A40R encodes a type II membrane glycoprotein with a C-type lectin-like domain at the C terminus. The A40 protein is not incorporated into virions, is nonessential for virus replication in cell culture and does not affect virus virulence in a murine intranasal model of infection. However, A40 does affect the outcome of infection in an intradermal infection model in which the virus lacking gene A40R produced smaller lesions and alterations in the host immune response. A40 has amino acid similarity to C-type lectins, such as NKG2A and DC-SIGN. Thi
APA, Harvard, Vancouver, ISO, and other styles
12

Junior, Anselmo Vasconcelos Rivetti. "Patogenia do Vaccinia Virus GP2 em bovinos." Universidade Federal de Minas Gerais, 2012. http://hdl.handle.net/1843/BUOS-95ZG22.

Full text
Abstract:
Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus (VACV), which affects dairy cattle and milkers, and causing economical, animal and human health impacts. By the clinical presentation of the disease, it seems that BV is a localized disease, with lesions restricted to the skin of affected individuals. But there are no studies about the pathogenesis of the disease in cows to access if there is a systemic spread of the virus and if there are different ways of VACV shedding. This work had the objective to study if occurs viremia and VACV shedding in the feces of VACV experimentally infe
APA, Harvard, Vancouver, ISO, and other styles
13

Rehfeld, Izabelle Silva. "Vaccinia bovina em vacas secas e lactantes experimentalmente inoculadas com o Vaccina virus." Universidade Federal de Minas Gerais, 2011. http://hdl.handle.net/1843/BUBD-9D7J9H.

Full text
Abstract:
This dissertation was divided into three experiments whose aims were to reproduce the bovine vaccínia (BV) in crossbred dairy and dry cows through the experimental inoculation with Vaccinia virus Guarani P2 (VACV-GP2). Experiment 1 studied the clinical and pathological evolution of the lesions and the localization of the virus by immuno-histochemistry in different stages of the disease. In this experiment, the teats of six crossbred dry cows, divided into three groups, were scarified with a hypodermic needle in the central area of each teat. Two groups were euthanized and necropsied in differe
APA, Harvard, Vancouver, ISO, and other styles
14

Law, Mansun. "Vaccinia virus spread : the roles of virus proteins, antibody and complement." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.365358.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Frischknecht, Friedrich. "Vaccinia virus mimics receptor tyrosine kinase signalling to achieve actin based motility." [S.l. : s.n.], 2000. http://www.diss.fu-berlin.de/2000/72/index.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Xing, Xuekun. "DNA replication and telomere resolution in vaccinia virus." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq23557.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Tseng, Michael. "Characterization of the vaccinia virus I3L gene product." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0003/MQ43227.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kenyon, Julia Claire. "The role of A41L in vaccinia virus immunogenicity." Thesis, Imperial College London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.424711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Haga, Ismar Rocha. "Characterisation of vaccinia virus genes A46R and A52R." Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.408267.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Price, Nicola. "Characterisation of vaccinia virus genes B7R and B9R." Thesis, University of Oxford, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325962.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Hiley, Crispin. "Arming vaccinia virus for pancreatic cancer oncolytic virotherapy." Thesis, Queen Mary, University of London, 2011. http://qmro.qmul.ac.uk/xmlui/handle/123456789/2344.

Full text
Abstract:
Vaccinia virus is a 250-300nm enveloped DNA virus from the poxvirus family and is used as a vector for oncolytic viral gene therapy. No unique cell surface receptor has been identified for Vaccinia virus and the reasons for its tropism for cancer cells are unclear. Pancreatic adenocarcinoma (PDAC) is resistant to conventional chemotherapy and typically contains areas that are profoundly hypoxic. We have investigated the utility of Vaccinia virus as a vector for targeting hypoxic regions in pancreatic adenocarcinoma, as other viral vectors have been found to replicate poorly in hypoxia. We foun
APA, Harvard, Vancouver, ISO, and other styles
22

Procter, Dean Joseph. "Genetic contribution to cytopathic effect in Vaccinia virus." Thesis, The University of Sydney, 2014. http://hdl.handle.net/2123/12502.

Full text
Abstract:
Vaccinia virus (VACV) infection induces cell migration, the formation of cytoplasmic extensions, actin polymerisation, cell rounding, detachment and lysis—changes collectively known as cytopathic effects (CPEs). Identification of genes that contribute to CPE phenotypes may highlight important virulence factors or novel signaling processes during infection. This investigation has focused on characterising four VACV genes (A55R, C2L, F3L and F5L) that have been identified as contributors to CPE. VACV protein F5 is a predicted membrane protein that is truncated in modified virus Ankara (MVA), a h
APA, Harvard, Vancouver, ISO, and other styles
23

McKenzie, Christopher David. "Activation of oncogenic signalling pathways by vaccinia virus." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15789.

Full text
Abstract:
Vaccinia virus (VACV) is a dsDNA virus and a member of the Poxviridae family. VACV induces a wide range of morphological changes to cells during infection, collectively known as cytopathic effect (CPE). VACV-induced CPE includes loss of cell–cell contacts between neighbouring cells, induction of cell migration and extensive remodelling of the actin cytoskeleton in order to aid viral egress. These characteristic changes during VACV infection closely resemble the changes associated with epithelial-mesenchymal transition (EMT) — an important process in development, wound healing and cancer progre
APA, Harvard, Vancouver, ISO, and other styles
24

Pfanzelter, Julia. "The role of septins during vaccinia virus spread." Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10042029/.

Full text
Abstract:
Septins are highly conserved components of the cytoskeleton found in animals and fungi. They play a variety of roles in key cellular processes including cell division, cell migration and membrane trafficking. During host-pathogen interactions, septins inhibit bacterial infection by forming cage-like structures around pathogens such as Shigella. In addition, two recent genome-wide RNAi screens demonstrated that septins play an undefined role during vaccinia virus replication. Utilizing cell-based assays and microscopy I set out to determine the role of septins in vaccinia infected cells. I foun
APA, Harvard, Vancouver, ISO, and other styles
25

Wanas, Essam A. "Cloning and expression of the glycoproteins of pichinde virus by vaccinia virus." Thesis, University of Ottawa (Canada), 1993. http://hdl.handle.net/10393/6489.

Full text
Abstract:
Pichinde virus (Pic), like the other arenaviruses, possesses two glycoproteins, GP1 and GP2, that are derived by proteolytic cleavage from a precursor molecule, GPC. Within the arenaviruses, GP1 is the most heterogeneous protein, and GP1 of Pic differs from that of the other arenaviruses in having twice as many potential N-linked glycosylation sites, most of which appear to be utilized. In order to examine the effects of this heavy glycosylation on Pic GP1 structure and inmunogenicity, GPC of Pic was cloned and expressed in vaccinia virus. The recombinant vaccinia (vvGPC) expresses authentic P
APA, Harvard, Vancouver, ISO, and other styles
26

Pelin, Adrian. "Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential." Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39909.

Full text
Abstract:
Vaccinia virus has a large and still incompletely understood genome although several strains of this virus are already in clinical development. For the most part, clinical candidates have been attenuated from their wild type vaccine strains through deletion of metabolic genes like the viral thymidine kinase gene. In the present work, we thoroughly examined the genetic elements of vaccinia which could be modulated to improve tailor the virus as a cancer therapeutic. Using a variety of cancer cell lines and primary tumor explants, we performed a fitness assay that directly compares multiple wild
APA, Harvard, Vancouver, ISO, and other styles
27

Becker, Michelle Caitlin. "The Combination of Carboxylesterase-Expressing Oncolytic Vaccinia Virus and Irinotecan." Thèse, Université d'Ottawa / University of Ottawa, 2013. http://hdl.handle.net/10393/23653.

Full text
Abstract:
This project combines oncolytic Vaccinia virus (VV) with irinotecan (CPT-11) for the treatment of cancer. VV can infect, replicate in and destroy cancer cells, yet leave healthy cells relatively unaffected. CPT-11 is a chemotherapeutic of which ~5% is converted to the more active chemotherapeutic SN-38 by endogenous carboxylesterase (CE) enzymes. SN-38 is a topoisomerase I inhibitor that induces DNA double strand breaks, leading to growth arrest and apoptosis. Consequently, VV has been engineered to express a more effective isoform of the CE enzyme. The virus’ tumour tropism should restrict en
APA, Harvard, Vancouver, ISO, and other styles
28

Roberts, Kim Louise. "The egress and entry of extracellular enveloped vaccinia virus." Thesis, Imperial College London, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Cordeiro, Joao. "Modulation of Rho GTPase signalling during vaccinia virus infection." Thesis, University College London (University of London), 2009. http://discovery.ucl.ac.uk/17273/.

Full text
Abstract:
Infection by vaccinia virus leads to reorganization of the actin cytoskeleton, changes in cell adhesion, loss of contact inhibition and stimulation of cell motility. Previous work by the group has led to the identification of a viral gene, F11L, which is highly conserved among the orthopoxvirus genomes and is essential for this virus-induced cell mobility. F11L has been shown to interact with the RhoA but does not interact with the two other 'classical’ members of the family Rac1 and Cdc42. Understanding the molecular interaction of F11L and RhoA as well as investigating additional Rho binding
APA, Harvard, Vancouver, ISO, and other styles
30

Weisswange, Ina. "Analysis of Vaccinia virus actin tail nucleating complex dynamics." Thesis, University College London (University of London), 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.499526.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Price, Philip John Ritchie. "Leukocyte trafficking during infection with modified vaccinia virus Ankara." Diss., Ludwig-Maximilians-Universität München, 2014. http://nbn-resolving.de/urn:nbn:de:bvb:19-173737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Whilding, Lynsey May. "Activity of oncolytic vaccinia virus vectors in ovarian cancer." Thesis, Queen Mary, University of London, 2012. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8553.

Full text
Abstract:
Oncolytic vaccinia virus has great potential in the treatment of cancer and two engineered strains have entered clinical trials. As the advent for oncolytic vaccinia virus as an approved therapy beckons, it is critical to consider some of the barriers that may hinder this progress. These include suboptimal delivery of the virus to tumour sites, incomplete destruction of the tumour mass, and a lack of full understanding of the way in which oncolytic vaccinia kills its target cells. This thesis attempts to address these issues, with a particular focus on ovarian cancer. As ovarian cancer is gene
APA, Harvard, Vancouver, ISO, and other styles
33

Gao, William Ning Da. "Viral and cellular proteins involved in vaccinia virus egress." Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/280280.

Full text
Abstract:
Vaccinia virus (VACV) is a large double-stranded DNA virus with a cytoplasmic site of replication. It has a complex life cycle that produces two distinct infectious virion forms, Intracellular Mature Virions (IMVs) and Extracellular Enveloped Virions (EEVs). The host cell microtubule trafficking machinery is hijacked by the virus at three distinct positions of the viral life cycle. After virus entry, the virus cores are transported to pre-nuclear sites where they form viral factories that ultimately produce fully functional and infectious IMVs. A small proportion of IMVs are further transporte
APA, Harvard, Vancouver, ISO, and other styles
34

Dave, Rajiv Vipool. "Oncolytic vaccinia virus for the treatment of liver cancer." Thesis, University of Leeds, 2014. http://etheses.whiterose.ac.uk/6887/.

Full text
Abstract:
Aims: Current treatment of colorectal cancer (CRC) liver metastases has a success rate of 50% 5-year survival, and recurrence rates of 50%. There is therefore still a need for a novel treatment modality. We aimed to examine the ability of JX-594 to preferentially replicate in and kill CRLM in vitro and ex vivo, and induce immunemediated tumour cytotoxicity by activation of natural killer (NK) cells. Methods: The Wyeth strain of vaccinia virus has been genetically manipulated to encode for granulocyte macrophage colony stimulating factor (JX-594-GM-CSFfLuc) and green fluorescent protein (JX-594
APA, Harvard, Vancouver, ISO, and other styles
35

Laporte, Aimée N. "Enhancing the Oncolytic Efficacy of Vaccinia Virus by Mutagenic Augmentation of EEV Production." Thèse, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/23348.

Full text
Abstract:
Oncolytic viruses are currently under investigation as anti - cancer therapies due to their innate ability to selectively infect and destroy cancer cells. Major barriers to this anti - tumour effect include inefficient viral spread and immune - mediated neutralization. This study aims to overcome these limitations by taking advantage of the life cycle of the oncolytic clinical candidate known as vaccinia virus (VACV). Naturally, a small proportion (<1%) of VACV progeny are released from infected cells with a cell - derived membrane and become known as extra - cellular enveloped virus (EEV
APA, Harvard, Vancouver, ISO, and other styles
36

Dunstan, Kerrie Women's &amp Children's Health Faculty of Medicine UNSW. "Understanding the early interactions between vaccinia virus and dendritic cells - towards an enhanced vaccine vector." Awarded by:University of New South Wales. Women's and Children's Health, 2007. http://handle.unsw.edu.au/1959.4/32456.

Full text
Abstract:
In the post smallpox era, vaccinia virus (VACV) has emerged as an important candidate vaccine vector. As yet, the binding receptors and entry mechanisms utilised by the two infectious forms, IMV and EEV, in dendritic cells (DCs) are unknown. We have investigated the interactions between VACV and C-type lectin receptors (CLRs) that are known to be utilised by many other viruses for binding and entry in DCs. Using a variety of CLR ligands and inhibitors we were unable to inhibit IMV or EEV binding to MDDCs and we conclude that they do not bind to CLRs. We have also investigated VACV entry in MDD
APA, Harvard, Vancouver, ISO, and other styles
37

Scheubeck, Gabriel Maria [Verfasser]. "Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus / Gabriel Maria Scheubeck." Tübingen : Universitätsbibliothek Tübingen, 2021. http://d-nb.info/1226756654/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Sullivan, Veronica. "Analysis of the herpes simplex virus type 1 glycoproteins using recombinant vaccinia virus vectors." Thesis, University of Cambridge, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.292957.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Veyer, David. "Comparaison des propriétés antiapoptotiques de quatre protéines du virus de la vaccine en isolement et au cours de l’infection virale." Thesis, Rennes 1, 2014. http://www.theses.fr/2014REN1B015/document.

Full text
Abstract:
L’apoptose, mort cellulaire observée suite à l’activation des caspases effectrices, est un moyen de défense contre les pathogènes, en particulier les virus. Le virus de la vaccine (VACV) est un virus contenant un grand génome à ADN codant pour environ 200 protéines, dont plusieurs inhibent l’apoptose. Cette apparente redondance fonctionnelle complique l’étude des protéines antiapoptotiques du virus dans un contexte d’infection virale. Dans ce travail, nous comparerons les propriétés antiapoptotiques des protéines B13, F1, GAAP et N1 de VACV. Cette comparaison sera établie dans un premier temps
APA, Harvard, Vancouver, ISO, and other styles
40

Cresawn, Steven Gaines. "Genetic inquiry into vaccinia virus intermediate and late gene regulation." [Gainesville, Fla.] : University of Florida, 2005. http://purl.fcla.edu/fcla/etd/UFE0010102.

Full text
Abstract:
Thesis (Ph.D.)--University of Florida, 2005.<br>Typescript. Title from title page of source document. Document formatted into pages; contains 150 pages. Includes Vita. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
41

MacTavish, Heather L. "Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors." Thesis, University of Ottawa (Canada), 2010. http://hdl.handle.net/10393/28659.

Full text
Abstract:
Histone deacetylase inhibitors (HDI) dampen cellular immune response by decreasing interferon production and have been shown to increase the replication of Vesicular Stomatitis Virus and HSV. As attenuated tumour-selective oncolytic vaccinia viruses (VV) are already undergoing clinical evaluation, the goal of this study is to determine whether HDI can also enhance the potency of these poxviruses in infection-resistant cancer cell lines. Multiple HDIs were tested and Trichostatin A (TSA) was found to potently enhance the spread and replication of a tumour selective VV in several infection-resis
APA, Harvard, Vancouver, ISO, and other styles
42

Kent, Richard Keith. "Isolation and analysis of the vaccinia virus P4B gene promotor." Thesis, University of Cambridge, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.303279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Ahmad, Khawaja Muneer. "Mutagenesis and localisation studies on the vaccinia virus B7R protein." Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405439.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Van, Eijl Henriette Joselijn Leonie. "The distribution and topology of the vaccinia virus A36R protein." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.325640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Scutts, Simon Robert. "Investigations into the vaccinia virus immunomodulatory proteins C4 and C16." Thesis, University of Cambridge, 2017. https://www.repository.cam.ac.uk/handle/1810/275923.

Full text
Abstract:
Vaccinia virus (VACV) is the most intensively studied orthopoxvirus and acts as an excellent model to investigate host-pathogen interactions. VACV encodes about 200 proteins, many of which modulate the immune response. This study focusses on two of these: C16 and C4, that share 43.7 % amino acid identity. Given the sequence similarity, we explored whether C16 and C4 have any shared functions, whilst also searching for novel functions. To gain mechanistic insight, we sought to identify binding partners and determine the residues responsible. C16 has two reported functions. Firstly, it inhibits
APA, Harvard, Vancouver, ISO, and other styles
46

Evans, Elizabeth Van Amburg. "Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication /." Access full-text from WCMC, 1989. http://proquest.umi.com/pqdweb?did=744576211&sid=1&Fmt=2&clientId=8424&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Baloglu, Simge. "Applicability of vaccinia virus as cloning and expression vector for bacterial genes: mice immune responses to vaccinia virus expressing Brucella abortus and Listeria monocytogenes antigens." Diss., Virginia Tech, 2001. http://hdl.handle.net/10919/28485.

Full text
Abstract:
Previous studies by our group showed that vaccinia virus recombinants expressing Brucella abortus (BA) antigens heat shock protein GroEL, 18 kDa protein and Cu/Zn SOD, were unable to induce protective immune responses against Brucella challenge. This dissertation analyzes the possible reasons for this phenomenon, by using other genes/proteins from BA and Listeria monocytogenes (LM), various shuttle plasmids (pSC65, pSC11) and immune response modulators (CpG, IL-12, B7-1). As the first objective, a vaccinia virus recombinant (WRL7/L12), expressing the BA L7/L12 gene was generated. L7/L12 ri
APA, Harvard, Vancouver, ISO, and other styles
48

Griffiths, Caroline Mary. "The cloning and expression of Herpes simplex virus type 1 glycoprotein C in vaccinia virus." Thesis, University of Leicester, 1991. http://hdl.handle.net/2381/35382.

Full text
Abstract:
The Herpesviridae family contains numerous virus types, several of which can infect man. The virus which is most widely spread in terms of infection is herpes simplex virus (HSV), of which there are two serotypes (HSV-1 and HSV-2). Following a primary infection, the virus can establish a latent infection within neurons of sensory ganglia, where it remains throughout the lifetime of the host. HSV is able to reactivate from the latent state, and may produce clinical infection at the site of the initial virus invasion (recrudescent lesions). Although most HSV-1 infections are mild or subclinical,
APA, Harvard, Vancouver, ISO, and other styles
49

Nie, Siwei. "Role of TNF in Heterologous Immunity between Lymphocytic Choriomeningitis Virus and Vaccinia Virus: A Dissertation." eScholarship@UMMS, 2008. https://escholarship.umassmed.edu/gsbs_diss/394.

Full text
Abstract:
Prior immunity to a related or unrelated pathogen greatly influences the host’s immune response to a subsequent infection and can cause a dramatic difference in disease course, a phenomenon known as heterologous immunity. Heterologous immunity can influence protective immunity, immunopathology and/or immune deviation of cytokine-producing T cell subsets. Examples of heterologous immunity have been well documented in mouse models, as well as during human infections. For example, prior immunity to lymphocytic choriomeningitis virus (LCMV) provides partial protection against vaccinia virus (VV),
APA, Harvard, Vancouver, ISO, and other styles
50

Alharbi, Naif K. "New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:bbde86fd-ea8f-4e66-b260-f923d7e01e4b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!